Trials / Conditions / Spinocerebellar Ataxias

Spinocerebellar Ataxias

27 registered clinical trials studyying Spinocerebellar Ataxias — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Use of a New Smartphone Application to Determine Changes in Eyeblink Conditioning From Home Training in Indivi NCT06177626	Columbia University	N/A
Not Yet Recruiting	Stemchymal® for Polyglutamine Spinocerebellar Ataxia NCT06397274	Steminent US, Inc.	Phase 2
Not Yet Recruiting	Efficacy of Cerebellar Transcranial Magnetic Stimulation to Treat Hereditary Spinocerebellar Ataxias NCT06898645	Xijing Hospital	N/A
Recruiting	Cycling-Based Priming Coordination Training for Enhancing Ataxia Recovery and Brain Plasticity NCT06600269	Chang Gung University	N/A
Unknown	rTMS Improves Functions in Spinocerebellar Ataxia NCT05973019	Changhua Christian Hospital	N/A
Completed	Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxi NCT05436262	Johns Hopkins University	N/A
Completed	Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38 NCT05951010	University of Cagliari	N/A
Completed	Effect of Training on Brain Volume in Ataxia NCT04837027	Columbia University	N/A
Recruiting	Biomarker Research in Inherited Movement Disorders NCT05034172	Assistance Publique - Hôpitaux de Paris	—
Withdrawn	Study of CAD-1883 for Spinocerebellar Ataxia NCT04301284	Cadent Therapeutics	Phase 2
Completed	Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia NCT05621200	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia	N/A
Completed	Ataxia and Exercise Disease Using MRI and Gait Analysis NCT03701776	Columbia University	N/A
Unknown	Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders NCT04231487	Rutgers, The State University of New Jersey	—
Active Not Recruiting	Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched NCT06529146	Biohaven Therapeutics Ltd.	—
Active Not Recruiting	Troriluzole in Adult Participants With Spinocerebellar Ataxia NCT03701399	Biohaven Pharmaceuticals, Inc.	Phase 3
Completed	Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia NCT04153110	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia	N/A
Completed	Aerobic Exercise, Balance Training, and Ataxia NCT03745248	Columbia University	N/A
Active Not Recruiting	Open Pilot Trial of BHV-4157 NCT03408080	University of California, Los Angeles	Phase 3
Completed	Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia NCT04595578	Samsung Medical Center	N/A
Active Not Recruiting	Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases NCT04529252	Mayo Clinic	—
Completed	Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia NCT03120013	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia	N/A
Completed	Trial in Adult Participants With Spinocerebellar Ataxia (SCA) NCT02960893	Biohaven Pharmaceuticals, Inc.	Phase 2 / Phase 3
Unknown	An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias NCT02287064	University of South Florida	Phase 1
Completed	Could Tai-chi Help Maintain Balance of Spinocerebellar Ataxia Patients NCT03687190	Changhua Christian Hospital	N/A
Completed	RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7 NCT01037777	Institut National de la Santé Et de la Recherche Médicale, France	—
Completed	Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degen NCT00136630	Institut National de la Santé Et de la Recherche Médicale, France	—
Available	Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA) NCT06034886	Biohaven Pharmaceuticals, Inc.	—